Obesity: What mental health professionals need to know

被引:129
作者
Devlin, MJ
Yanovski, SZ
Wilson, GT
机构
[1] New York State Psychiat Inst & Hosp, Unit 116, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA
[3] NIDDKD, Obes & Eating Disorders Program, Bethesda, MD 20892 USA
[4] Rutgers State Univ, Rutgers Eating Disorder Clin, Piscataway, NJ USA
关键词
D O I
10.1176/appi.ajp.157.6.854
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Obesity is a highly prevalent condition with significant health implications. This report summarizes recent clinically relevant findings concerning the pathogenesis and treatment of obesity and considers their implications for psychiatric diagnosis and management. Method: The authors conducted selective reviews of the literature from the last 10 years. Topics included the biological and behavioral factors that contribute to the onset and maintenance of obesity, the relationship between obesity and psychiatric illness and treatment, and the questions of whether and how obesity should be treated. Results: Genetic effects, some mediated by eating behavior, contribute importantly to the potential for obesity, the expression of which is promoted by environmental factors that increase the availability of calorically dense foods and discourage activity. There appear to be behaviorally distinct subsets of obese persons who display particular patterns of disordered eating and elevated rates of psychopathology. Treatment with psychotropic medications may contribute to obesity in ways that are only partly understood. Although successful obesity treatment is associated with clear health benefits and available treatments offer benefit to some, relapse remains the rule. Conclusions: Although the presence or development of obesity is a daunting problem, it should not be ignored by mental health professionals. Treatment should address not only obesity per se, but also its effects on self-esteem in a hostile cultural climate. Ongoing developments in basic and clinical research are likely to increase the range, efficacy, and acceptability of treatment options in the years ahead.
引用
收藏
页码:854 / 866
页数:13
相关论文
共 158 条
[1]   Bodyweight gain induced by psychotropic drugs - Incidence, mechanisms and management [J].
Ackerman, S ;
Nolan, LJ .
CNS DRUGS, 1998, 9 (02) :135-151
[2]  
Ailhaud G., 1998, HDB OBESITY, P359
[3]  
Allison DB, 1996, INT J OBESITY, V20, P501
[4]  
[Anonymous], 1993, JAMA, V270, P967
[5]  
[Anonymous], 1992, Arch Gen Psychiatry, V49, P139
[6]  
[Anonymous], 1998, OB PREV MAN GLOB EP
[7]  
ATKINSON RL, 1994, JAMA-J AM MED ASSOC, V272, P1196, DOI 10.1001/jama.272.15.1196
[8]   Absence of cardiac valve dysfunction in obese patients treated with sibutramine [J].
Bach, DS ;
Rissanen, AM ;
Mendel, CM ;
Shepherd, G ;
Weinstein, SP ;
Kelly, F ;
Seaton, TB ;
Patel, B ;
Pekkarinen, TA ;
Armstrong, WF .
OBESITY RESEARCH, 1999, 7 (04) :363-369
[9]  
BALLOR DL, 1998, HDB OBESITY, P891
[10]   ENERGY-EXPENDITURE IN OBESE AND NONOBESE ADOLESCENTS [J].
BANDINI, LG ;
SCHOELLER, DA ;
DIETZ, WH .
PEDIATRIC RESEARCH, 1990, 27 (02) :198-203